This groundbreaking study highlights that elevated cholesterol levels in lipid rafts play a pivotal role in inducing gefitinib resistance in NSCLC cells by impacting EGFR phosphorylation, downstream signaling pathways, and EGFR-TKI affinity (Irwin et al., 2011) (Figure 3). Here, EGFR is linked to non-small cell lung carcinoma.